On May 21, 2024, Eminence Capital announced that it has built its stake in Reckitt Benckiser Group plc to at least 0.5% following record lows for the stock due to infant-formula litigation in the U.S. Eminence Capital stated that the Company's board could do more to improve its embattled operating margins, and its stake will likely increase calls for the sale of the Company's baby formula division.